Čes-slov Pediat 2022, 77(4):214 | DOI: 10.55095/CSPediatrie2022/034

Genetic diversity of monogenic diabetes in UkraineAbstrakta

Evgenia Globa¹, Natalia Zelinska¹, Jan Lebl², Elisa De Franco³, Kevin Colclough⁴

¹ Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine

² Department of Pediatrics, 2^nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

³ Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom

⁴ Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom

Monogenic diabetes encompasses at least 70 different genetic subtypes that can be broadly categorized into neonatal diabetes, non-syndromic monogenic diabetes ( maturity-onset diabetes of the young - MODY), diabetes occurring as part of a monogenic syndrome with additional extra-pancreatic features, and monogenic autoimmune diabetes. The aim of this study is to elucidate the etiology and frequency of monogenic diabetes in a large diabetes database in Ukraine diagnosed after 9 months of age. We established a Monogenic Diabetes Register to identify patients with a clinical suspicion of MODY. 141 patients with diabetes diagnosed between 9 months and 32 years were selected from 138 unrelated families for genetic testing. The majority were selected from a Ukrainian Pediatric Diabetes Register (UPDR) which covered all Ukrainian regions (excluding occupied territories). All patients had com prehensive genetic testing for mutations in all known monogenic diabetes genes using targeted next generation sequencing. As of 2020, the UPDR contained 10,598 children aged <18 years with T1DM (1 in 710), 51 with T2DM (1 in 147,724) and 65 (1 in 115,906) with neonatal diabetes. 134/141 (95%) patients tested were diagnosed <18 years. A genetic diagnosis was confirmed in 63/141 (44.6% ) probands with a clinical suspicion of MODY. The median age at diagnosis was 11 years [IQR 6.7, 15.0] and 72% were not treated with insulin. 32% of probands had no parent with diabetes or impaired glucose tolerance. Mutations in non-syndromic diabetes genes were identified in 54/63 monogenic patients (85.7%) with GCK the most common genetic cause overall (46.1%), followed by HNF1A (GCK (n=29), HNF1A (n=15), HNF4A (n=5), ABCC8 (n=3) and INS (n=2). All patients with HNF1A, HNF4A and ABCC8 diabetes were able to transfer to sulfonylureas with significant improvement in glycemic control. Mutations in the syndromic diabetes genes HNF1B, WFS1, INSR, AIRE and MAFA accounted for the remaining 14.3% of cases. Some patients with MODY had atypical clinical presentation. E.g. one patient with the INS mutation p.(Arg46Gln) had severe hypoglycaemia, and the patient with a MAFA p.(Ser64Phe) was diagnosed with diabetes aged 28 years and subsequently developed hyperinsulinism due to an insulinoma. Genetic subtypes of monogenic diabetes within the Ukrainian population are diverse, and comprehensive testing of all genes is required for accurate diagnosis and improvement in clinical care.

Zveřejněno: 25. srpen 2022  Zobrazit citaci